Ultrahypofractionated Radiation Just As Effective for Prostate Cancer

Audio Journal of Oncology Podcast

Ultrahypofractionated Radiation Just As Effective for Prostate Cancer

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 / 11:00

Apple Podcasts Spotify Stitcher

RSS Feed

Share

Link

Embed

BARCELONA—Ultrahypofractionated radiation (U-HF) delivered in only seven fractions (each triple the usual dose) in two and a half weeks was just as effective for treating intermediate-risk prostate cancer—with no greater toxicity—as a standard protocol with 39 fractions over eight-weeks in findings from the phase 3 Scandinavian HYPO-RT-PC study reported at the 2018 European Society For Radiotherapy and Oncology (ESTRO 37) annual conference. http://www.mynewsdesk.com/se/umea_universitet/documents/abstract-prostatastudie-77805

Anders Widmark MD PhD, Professor of Oncology and Senior Consultant in the Department of Radiation Oncology and the Umeå University Hospital Cancer Centre in Umeå, North Sweden talks with the Audio Journal of Oncology about why they undertook their study and about the clinical implications of their findings.